Search

Esma S Yolcu

from Columbia, MO
Age ~62
Get Report
Also known as:
Esma S Shirwan, Haval Shirwan, Esma Womer
Related to:
Anna GuerraRosana Silva, 44Heather L Cirner, 50Alcides Guerra, 77Schenrer Guerra, 74
Connected to:
Lubomyra A Yoldas, 78Carolina K Yolen, 49Jennifer M Yoli, 42Michael A Yolken, 71Stanley F Yolkiewicz, 77David C Yolleck, 70Dylan Yolles, 55Melanie A Yolles, 70Amanda M Yollin, 41Erin M Yolo, 39

Esma Yolcu Phones & Addresses

  • Columbia, MO
  • 17018 Mallet Hill Dr, Louisville, KY 40245 (502) 244-9562
  • Lake City, FL
  • 100 Glenolden Ave, Glenolden, PA 19036 (610) 522-5165
  • 17018 Mallet Hill Dr, Louisville, KY 40245 (502) 594-6352

Education

Degree: High school graduate or higher

Emails

h***[email protected]

Resumes

Resumes

Esma Yolcu Photo 1

Assistant Professor

View page
Location:
2800 south Floyd St, Louisville, KY 40209
Industry:
Higher Education
Work:
University of Louisville
Assistan Professor
Education:
University of Louisville 1999
Ankara University
Skills:
Cell Culture
Molecular Biology
Cell Biology
Animal Models
Flow Cytometry
Biochemistry
University Teaching
Western Blotting
Science
Pcr
Higher Education
Microscopy
Protein Expression
Rt Pcr
Cancer Research
Research
Reverse Transcription Polymerase Chain Reaction
Esma Yolcu Photo 2

Assistant Prof. At University Of Louisville

View page
Position:
Assistant Prof. at University of Louisville
Location:
Louisville, Kentucky Area
Industry:
Hospital & Health Care
Work:
University of Louisville
Assistant Prof.
Education:
University of Louisville 1999

Publications

Us Patents

Immunostimulatory Compositions And Methods

View page
US Patent:
8017582, Sep 13, 2011
Filed:
Sep 3, 2009
Appl. No.:
12/553770
Inventors:
Haval Shirwan - Louisville KY, US
Kutlu G. Elpek - Louisville KY, US
Esma S. Yolcu - Louisville KY, US
Assignee:
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A61K 38/16
US Classification:
514 212
Abstract:
The invention provides conjugates comprising an immune co-stimulatory polypeptide and an antigen or infectious agent. The conjugates are useful for generating or enhancing an immune response against the antigen or infectious agent. The invention also provides immune cells modified with a conjugate that are useful for generating or enhancing an immune response to an antigen or infectious agent. The invention also provides immunostimulatory moieties comprising an immune co-stimulatory polypeptide that are useful for stimulating an immune response. The invention also provides immunotherapy methods and methods of treating or preventing infections.

In Vivo Cell Surface Engineering

View page
US Patent:
20070172504, Jul 26, 2007
Filed:
Dec 7, 2006
Appl. No.:
11/635075
Inventors:
Haval Shirwan - Louisville KY, US
Kutlu Elpek - Louisville KY, US
Esma Yolcu - Louisville KY, US
International Classification:
A61K 39/00
C12N 5/08
C12N 15/09
US Classification:
424277100, 435325000, 435366000, 435455000
Abstract:
The present invention provides methods and compositions for the in vivo engineering of cell surfaces, such as tumor cell surfaces, with one or more immune co-stimulatory polypeptides. The methods, compositions and engineered cells are useful, for example, to stimulate an immune response against the cells. When the engineered cell surfaces are tumor cell surfaces, the methods, compositions and engineered cells are useful for improving a patient's immune response against the cancer and for reducing tumor size and inhibiting tumor growth.

Immunostimulatory Compositions And Methods

View page
US Patent:
20070184473, Aug 9, 2007
Filed:
Dec 7, 2006
Appl. No.:
11/635066
Inventors:
Haval Shirwan - Louisville KY, US
Kutlu Elpek - Louisville KY, US
Esma Yolcu - Louisville KY, US
International Classification:
C12Q 1/68
C12P 21/06
US Classification:
435006000, 435069100
Abstract:
The invention provides conjugates comprising an immune co-stimulatory polypeptide and an antigen or infectious agent. The conjugates are useful for generating or enhancing an immune response against the antigen or infectious agent. The invention also provides immune cells modified with a conjuagte that are useful for generating or enhancing an immune response to an antigen or infectious agent. The invention also provides immunostimulatory moieties comprising an immune co-stimulatory polypeptide that are useful for stimulating an immune response. The invention also provides immunotherapy methods and methods of treating or preventing infections.

In Vivo Cell Surface Engineering

View page
US Patent:
20100240585, Sep 23, 2010
Filed:
Jul 8, 2009
Appl. No.:
12/499488
Inventors:
Haval Shirwan - Louisville KY, US
Kutlu G. Elpek - Louisville KY, US
Esma S. Yolcu - Louisville KY, US
International Classification:
A61K 38/16
C12N 5/02
C07K 14/00
A61P 35/00
US Classification:
514 12, 435375, 530350
Abstract:
The present invention provides methods and compositions for the in vivo engineering of cell surfaces, such as tumor cell surfaces, with one or more immune co-stimulatory polypeptides. The methods, compositions and engineered cells are useful, for example, to stimulate an immune response against the cells. When the engineered cell surfaces are tumor cell surfaces, the methods, compositions and engineered cells are useful for improving a patient's immune response against the cancer and for reducing tumor size and inhibiting tumor growth.

Immunostimulatory Compositions And Methods

View page
US Patent:
20120171240, Jul 5, 2012
Filed:
Sep 7, 2011
Appl. No.:
13/227162
Inventors:
Haval Shirwan - Louisville KY, US
Kutlu G. Elpek - Louisville KY, US
Esma S. Yolcu - Louisville KY, US
International Classification:
A61K 39/00
C07K 14/77
C07K 14/705
A61K 39/02
A61P 33/00
A61P 35/00
A61P 31/00
A61P 37/04
A61P 31/04
A61P 31/12
C12N 5/078
A61K 39/12
US Classification:
42419611, 4241931, 435325, 530367, 530409, 42419711
Abstract:
The invention provides conjugates comprising an immune co-stimulatory polypeptide and an antigen or infectious agent. The conjugates are useful for generating or enhancing an immune response against the antigen or infectious agent. The invention also provides immune cells modified with a conjugate that are useful for generating or enhancing an immune response to an antigen or infectious agent. The invention also provides immunostimulatory moieties comprising an immune co-stimulatory polypeptide that are useful for stimulating an immune response. The invention also provides immunotherapy methods and methods of treating or preventing infections.

Fasl-Engineered Biomaterials With Immunomodulatory Function

View page
US Patent:
20200046780, Feb 13, 2020
Filed:
Mar 9, 2018
Appl. No.:
16/492441
Inventors:
- Louisville KY, US
- Atlanta GA, US
Esma S. YOLCU - Louisville KY, US
Hong ZHAO - Louisville KY, US
Devon HEADEN - Atlanta GA, US
Assignee:
University of Louisville Research Foundation, Inc. - Louisville KY
Georgia Tech Research Corporation - Atlanta GA
International Classification:
A61K 35/39
A61K 31/436
A61K 38/17
A61K 35/15
A61K 35/28
A61K 47/60
A61K 47/69
C12N 15/85
A61P 3/08
Abstract:
Described herein are FasL-engineered biomaterials, as well as methods of making and using such FasL-engineered biomaterials, such as for immunomodulation, such as for inducing immunosuppression and specific immune tolerance, such as for preventing or reducing the risks of rejection of cellular or tissue grafts and/or the treatment of autoimmune disorders such as Type I diabetes. In specific embodiments, the FasL-engineered biomaterials are biotinylated microgels bound to SA-FasL.
Control profile
Esma S Yolcu from Columbia, MO, age ~62 Get Report